2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
32
Pain, Postoperative
18
Neoplasms
16
Parkinson Disease 4, Autosomal Dominant Lewy Body
13
Lung Neoplasms
12
Brain Neoplasms
12
Prostatic Neoplasms
9
Ovarian Neoplasms
9
Colonic Neoplasms
8
Carcinoma, Hepatocellular
8
Stomach Neoplasms
7
Depression
7
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Pain
6
Head and Neck Neoplasms
6
Thyroid Neoplasms
5
Pancreatic Neoplasms
5
Multiple Myeloma
5
Leiomyoma
5
Agnosia
5
Neoplasm Metastasis
4
Lymphoma
4
Fatigue
4
Delirium
4
Anxiety Disorders
4
Urinary Bladder Neoplasms
3
Thromboembolism
3
Supratentorial Neoplasms
3
Stomatitis
3
Interventions
Levetiracetam
6
Cannabidiol
5
perampanel
2
Tranexamic Acid
2
Standard of Care
2
Everolimus
2
ziprasidone
1
enzalutamide
1
Zolpidem
1
Warfarin
1
Vigabatrin
1
Vecuronium Bromide
1
Vancomycin
1
Tobramycin
1
Temozolomide
1
Spironolactone
1
Solutions
1
Sodium Chloride
1
Sevelamer
1
Saline Solution
1
Rocuronium
1
Remifentanil
1
Propofol
1
Pregabalin
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Seizures
×
Saline Solution
×
Clear all
NCT04595786
2025-03-04
STAMP
Beijing Tiantan Hospital
Phase NA
Completed
228 enrolled